Details for New Drug Application (NDA): 040510
✉ Email this page to a colleague
NDA 040510 describes ERGOTAMINE TARTRATE AND CAFFEINE, which is a drug marketed by Hikma Intl Pharms and Mikart and is included in two NDAs. It is available from one supplier. Additional details are available on the ERGOTAMINE TARTRATE AND CAFFEINE profile page.
The generic ingredient in ERGOTAMINE TARTRATE AND CAFFEINE is caffeine; ergotamine tartrate. There are eleven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the caffeine; ergotamine tartrate profile page.
The generic ingredient in ERGOTAMINE TARTRATE AND CAFFEINE is caffeine; ergotamine tartrate. There are eleven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the caffeine; ergotamine tartrate profile page.
Summary for 040510
| Tradename: | ERGOTAMINE TARTRATE AND CAFFEINE |
| Applicant: | Hikma Intl Pharms |
| Ingredient: | caffeine; ergotamine tartrate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 100MG;1MG | ||||
| Approval Date: | Sep 17, 2004 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
